De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene

Clinical Cancer Research

Volumn 13, Issue 20, 2007, Pages 6001-6009

  Ikegaki, Naohiko ^a   Gotoh, Takahiro ^b   Kung, Bing ^c   Riceberg, Justin S ^c   Kim, David Y ^c   Zhao, Huaqing ^c   Rappaport, Eric F ^c   Hicks, Sakeenah L ^d   Seeger, Robert C ^e   Tang, Xao X ^a,f  

^a UNIVERSITY OF ILLINOIS   (United States)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

^f CME ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; 5 AZA 2' DEOXYCYTIDINE; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA METHYLTRANSFERASE INHIBITOR; GLUCOCORTICOID; HISTONE DEACETYLASE INHIBITOR; MYC PROTEIN; PROTEIN MIZ 1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ARTICLE; CANCER GROWTH; CD44 GENE; CHILDHOOD CANCER; CONTROLLED STUDY; DNA FINGERPRINTING; EFNB2 GENE; EFNB3 GENE; EPHB6 GENE; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; NEUROBLASTOMA; NEUROBLASTOMA GENE; NTRK1 GENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOCORTICOIDS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-MYC; TREATMENT OUTCOME; ZINC FINGERS;

EID: 35948975740     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0071     Document Type: Article

References (32)

1. Tang XX, Zhao H, Robinson ME, et al. Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proc Natl Acad Sci U S A 2000;97: 10936-41.
2. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 1993;328:847-54.
3. Eggert A, Grotzer MA, Ikegaki N, Liu XG, Evans AE, Brodeur GM. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells. Cancer Res 2002;62:1802-8.
4. Combaret V, Gross N, Lasset C, et al. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J Clin Oncol 1996;14: 25-34.
5. Gross N, Balmas Bourloud K, Brognara CB. MYCN-related suppression of functional CD44 expression enhances tumorigenic properties of human neuroblastoma cells. Exp Cell Res 2000;260:396-403.
6. Tang XX, Robinson ME, Riceberg JS, et al. Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma. Clin Cancer Res 2004;10:5837-44.
7. Bogenmann E, Peterson S, Maekawa K, Matsushima H. Regulation of NGF responsiveness in human neuroblastoma. Oncogene 1998;17:2367-76.
8. Pignatelli M, Cortes-Canteli M, Santos A, Perez-Castillo A. Involvement of the NGFI-A gene in the differentiation of neuroblastoma cells. FEBS Lett 1999; 461:37-42.
9. Eggert A, Ikegaki N, Liu X, et al. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells. Oncogene 2000;19:2043-51.
10. Cibelli G, Policastro V, Rossler OG, Thiel G. Nitric oxide-induced programmed cell death in human neuroblastoma cells is accompanied by the synthesis of Egr-1, a zinc finger transcription factor. J Neurosci Res 2002;67:450-60.
11. Pignatelli M, Luna-Medina R, Perez-Rendon A, Santos A, Perez-Castillo A. The transcription factor early growth response factor-1 (EGR-1) promotes apoptosis of neuroblastoma cells. Biochem J 2003;373:739-46.
12. Tang XX, Brodeur GM, Campling BG, Ikegaki N. Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma. Clin Cancer Res 1999;5:455-60.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53: 457-81.
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
15. Cox DR. Regression models and lifetables. J R Stat Soc-B 1972;74:187-220.
16. Ikegaki N, Kennett RH. Glutaraldehyde fixation of the primary antibody-antigen complex on nitrocellulose paper increases the overall sensitivity of immunoblot assay. J Immunol Methods 1989;124:205-10.
17. de Ruijter AJ, Kemp S, Kramer G, et al. The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells. Biochem Pharmacol 2004;68:1279-88.
18. Glick RD, Swendeman SL, Coffey DC, et al. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma. Cancer Res 1999;59:4392-9.
19. Singh TR, Shankar S, Srivastava RK. HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma. Oncogene 2005;24: 4609-23.
20. Peukert K, Staller P, Schneider A, Carmichael G, Hanel F, Eilers M. An alternative pathway for gene regulation by Myc. EMBO J 1997;16:5672-86.
21. Tang XX, Zhao H, Kung B, et al. The MYCN enigma: significance of MYCN expression in neuroblastoma. Cancer Res 2006;66:2826-33.
22. Ross RA, Hein AM, Braca JA III, Spengler BA, Biedler JL, Scammell JG. Glucocorticoids induce neuroendocrine cell differentiation and increase expression of N-myc in N-type human neuroblastoma cells. Oncol Res 2002;13:87-94.
23. Williams LR, Sandquist D, Black AC, Jr., Williams TH. Glucocorticoids increase tyrosine hydroxylase activity in cultured murine neuroblastoma. J Neurochem 1981; 36:2057-62.
24. Sandquist D, Williams TH, Sahu SK, Kataoka S. Morphological differentiation of a murine neuroblastoma clone in monolayer culture induced by dexamethasone. Exp Cell Res 1978;113:375-81.
25. Thomassin H, Flavin M, Espinas ML, Grange T. Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J 2001;20: 1974-83.
26. Staller P, Peukert K, Kiermaier A, et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol 2001;3:392-9.
27. Seoane J, Le HV, Massague J. Myc suppression of the p21 (Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 2002;419: 729-34.
28. Herold S, Wanzel M, Beuger V, et al. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol Cell 2002;10: 509-21.
29. Maris JM, Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol 1999;17:2264-79.
30. Patel JH, McMahon SB. Targeting of Miz-1 is essential for Myc-mediated apoptosis. J Biol Chem 2006; 281:3283-9.
31. Caron H, van Sluis P, van Hoeve M, et al. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet 1993;4:187-90.
32. Maris JM, Weiss MJ, Guo C, et al. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. J Clin Oncol 2000;18:1888-99.